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ABSTRACT
Gynura procumbens, a medicinal plant locally known as Sambung nyawa, is widely used traditionally in South 
East Asia as a remedy to alleviate symptoms of various ailments including diabetes mellitus. Previous investigators 
reported that the ethanol plant extract was hypoglycemic in streptozotocin (STZ)-induced diabetic rats and suggested 
the blood glucose-reducing effect could be due to G. procumbens mimicking insulin effects. Our present study aimed 
to reevaluate the hypoglycemic effect(s) of G. procumbens and to ascertain the involvement of glycogen synthase 
kinase (GSK3), a key component of insulin biosignaling in the plant activity. A cell-based assay showed that the three 
G. procumbens fractions tested did not exhibit anti-GSK3 activities. Oral administrations of hexane, ethyl acetate, 
n-butanol fractions of G. procumbens (250 mg/kg b.w.) and Glibenclamide (5 mg/kg b.w.) for 14 days in STZ-induced 
diabetic rats reduced blood glucose levels by 29.7%, 60.1%, 33.5% and 61.7% (p<0.05), respectively compared to 
diabetic control. Liver glycogen contents were elevated (p<0.05), following administration of the three fractions of 
G. procumbens in diabetic rats when analysed after 14 days of treatment. Western blot analysis also showed GSK3β 
in the liver of G. procumbens fractions-treated and Glibenclamide-treated animals were phosphorylated at Ser-9. 
The above findings indicated that the hypoglycemic action of G. procumbens fractions resulted in the inactivation of 
GSK3β in liver of diabetic rats. Since G. procumbens fractions did not exhibit GSK3 inhibitory properties, it is possible 
that the hypoglycemic action of the fractions observed here could be due to direct or indirect effects on upstream 
components of the insulin biosignaling pathway. 
Keywords: GSK3; Gynura procumbens; hypoglycemic activity; streptozotocin
ABSTRAK
Gynura procumbens, sejenis tumbuhan ubatan yang lazimnya dikenali sebagai Sambung nyawa digunakan secara 
meluas di Asia Tenggara untuk meringankan simptom pelbagai penyakit termasuk diabetes mellitus. Kajian-kajian 
sebelum ini menunjukkan ekstrak etanol tumbuhan tersebut bersifat hipoglisemik terhadap tikus diabetes aruhan-
streptozotocin (STZ) dan mencadangkan kesan pengurangan glukosa darah ini kemungkinannya disebabkan keupayaan 
G. procumbens memberikan kesan menyerupai insulin. Kajian ini bertujuan untuk menilai semula kesan hipoglisemik 
fraksi etanol G. procumbens serta menentukan sama ada GSK3, sebagai satu komponen utama pengisyaratan insulin, 
terlibat. Tiga fraksi G. procumbens yang diuji melalui pengasaian berasas-sel tidak menunjukkan aktiviti anti-GSK3. 
Pemberian secara oral fraksi heksana, etil asetat, n-butanol G. procumbens (250 mg/kg b.w.) dan Glibenklamida 
(5 mg/kg b.w.) selama 14 hari kepada tikus diabetes aruhan-STZ mengurangkan aras glukosa darah masing-masing 
sebanyak 29.7%, 60.1%, 33.5% dan 61.7% (p<0.05) berbanding kawalan diabetes. Kandungan glikogen hepar 
tikus diabetes yang diperlakukan dengan ketiga-tiga fraksi G. procumbens didapati meningkat (p<0.05) apabila 
dianalisis selepas 14 hari perlakuan. Analisis pemblotan western juga menunjukkan GSK3β dalam hepar tikus diabetes 
yang diperlakukan dengan fraksi G. procumbens dan Glibenklamida adalah dalam keadaan terfosfat pada Ser-9. 
Secara keseluruhannya, hasil kajian ini menunjukkan tindakan hipoglisemik fraksi G. procumbens mengakibatkan 
penyahaktifan GSK3β dalam hepar tikus diabetes. Oleh sebab fraksi tumbuhan ini sendiri tidak mempamerkan sifat 
perencatan GSK3, aktiviti hipoglisemik fraksi tersebut mungkin secara langsung atau tidak melibatkan satu atau lebih 
komponen huluan tapak jalan pengisyaratan insulin. 
Kata kunci: Aktiviti hipoglisemik; GSK3; Gynura procumbens; streptozotocin
INTRODUCTION
Diabetes mellitus is a metabolic disease characterised 
by disordered metabolism and abnormally high levels of 
blood glucose. It is a major public health problem affecting 
285 million or 6.4% of the world population for the year 
2010 (International Diabetes Federation 2009). By 2030, 
this number is estimated to rise to 435 million. Despite 
considerable progress in the management of diabetes 
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mellitus using synthetic drugs, the search for improved and 
safe natural anti-diabetic agents with minimal side effects 
is ongoing. 
 Gynura procumbens Merr. (Compositae), locally 
known as Sambung Nyawa or Kecam Akar is an evergreen 
shrub with medicinal properties widely distributed in 
South East Asia. It has been used by rural communities 
to treat various ailments including diabetes (Perry 1980). 
The ethanol and methanol extracts prepared from leaves 
of the plant were reported to exhibit anti-diabetic effects 
in streptozotocin (STZ)-induced diabetic rats (Akowuah 
et al. 2001a,b; Zhang & Tan 2000). In addition, Rasadah 
et al. (2002) showed that the methanol extract of G. 
procumbens was able to increase insulin secretion in the 
insulin-secreting cell line, BRIN-BD11.
 More recently, it was reported that the aqueous extract 
of G. procumbens not only decreased the blood glucose 
levels but also caused an increase in the glucose uptake 
by muscle tissues in STZ-induced diabetic rats (Zurina 
et al. 2010). In contrast to what was reported earlier by 
Rasadah et al. (2002), there were no significant changes 
in plasma insulin levels in the diabetic rats following 
administration with the extract (Zurina et al. 2010). Zurina 
et al. (2010) also proposed that the hypoglycemic effect 
observed could be attributed to the phytoconstituents of 
G. procumbens mimicking insulin action by promoting 
glucose uptake. However, no experimental evidence was 
provided to show the involvement of any component of 
the insulin biosignaling pathway for the effect observed. 
In addition to stimulating glucose uptake, insulin promotes 
phosphorylation and inhibition of glycogen synthase 
kinase 3 (GSK3), a component of insulin biosignaling 
(Lee & Kim 2007). GSK3 was first described in glycogen 
metabolism as an enzyme which phosphorylates and 
inactivates glycogen synthase, the rate-limiting enzyme in 
the synthesis of glycogen in response to insulin (Embi et al. 
1980). Although GSK3 is constitutively active in cells, it is 
inactivated in response to insulin stimulation of glycogen 
synthesis in muscles (Wang et al. 2009). The aim of the 
present study was to investigate the involvement of GSK3, 
a component of insulin biosignaling in the hypoglycemic 
effects of the active fractions from G. procumbens by 
examining the phosporylation state of GSK3 in the liver 
of normal and STZ-induced diabetic rats treated with the 
fractions. 
MATERIALS AND METHODS
PREPARATION AND FRACTIONATION OF 
G. PrOcumbENS LEAF EXTRACT
G. procumbens plants were collected from the Green 
House Facility at the Faculty of Science and Technology, 
Universiti Kebangsaan Malaysia. Fresh leaves from the 
plant were washed and air-dried at room temperature. 
The dried leaves (2 kg) were ground into a powder form, 
macerated and soaked with 95% ethanol (3 L) for three 
days at room temperature. This procedure was repeated 
thrice. The extracts were filtered and evaporated under 
reduced pressure at a temperature of 40°C using a rotary 
evaporator to give a residue. This crude extract was 
partitioned successively between hexane/water, ethyl 
acetate/water and n-butanol/water (Si et al. 2010). Then, 
each fraction was concentrated to dryness to obtain 
three fractions (hexane, ethyl acetate and n-butanol) for 
biological tests. The yields obtained for each fraction with 
respect to the initial dry material were hexane 5.4%, ethyl 
acetate 2.1% and n-butanol 2.9%. 
HPLC ANALYSIS OF G. PrOcumbENS FRACTIONS
The fractions were dissolved in 45% methanol as 3 mg/
mL, filtered through membrane filter and 20 µL injected for 
high-performance liquid chromatography (HPLC) analysis. 
HPLC-diode array detector-electrospray ionisation-tandem 
mass spectrometry (HPLC-DAD-ESI-MS) with Shimadzu 
shimpack VP ODS column (150 mm × 4.6 mm i.d., 5 µm 
particle size) was used for identification for the chemical 
compositions present in the fraction. The mobile phase 
consisted of water-0.1% formic acid (A) and acetonitrile 
(B) and a linear gradient program of 10-30% B in 0-30 
minutes, 30-100% B in 30-40 minutes was used at a flow 
rate of 0.8 mL/min and a setting of 347 nm for the DAD 
detector (Akowuah et al. 2001a, b).
CELL-BASED ASSAY FOR GSK3 INHIBITOR
In this assay, a yeast gsk-3 null mutant YTA003W with 
genotype mATahis3 leu2 ura3 trp1 ade2 mck1::TrP1 
mds1::HIS3 mrk1 yol128c::LEu2 was transformed 
with mammalian gsk3β. The yeast gsk3 null mutant 
is temperature sensitive at 37°C and this phenotype 
is suppressed by the expression of mammalian GSK3β 
(Andoh et al. 2000). The transformant was grown in 25 
mL of SC-Ura medium at 37°C with shaking at 180 rpm 
in an incubator (Jeio Tech Co., Ltd., Korea) for 2 days. A 
volume of 400 μL culture was inoculated into 100 mL of 
screening agar (0.67% yeast nitrogen base without amino 
acids and ammonium sulphate, 0.5% ammonium sulphate, 
2% D(+)-glucose anhydrate, 1 mL each of 0.03 mg/mL of 
adenine (hemisulphate salt), 0.03 mg/mL of L-tryptophan, 
0.03 mg/mL of L-leucine, 0.03 mg/mL of L-histidine and 
1.5% bacteriological agar, pH 5.6). 
 Paper disc diffusion assays were performed in 
the presence and absence of G. procumbens fractions 
dissolved in their respective solvent extraction at various 
concentrations and plates incubated at both permissive 
temperature (25ºC) and high temperature (37ºC). H7667, 
a Streptomycete toxic to yeast was used as the positive 
control (Cheenpracha et al. 2009) in this assay. Growth 
was scored after 5 days.
EXPERIMENTAL ANIMALS
Male Sprague-Dawley rats (n = 36) aged six weeks 
and weighing approximately 250 g were obtained from 
the Animal House Facility at the Faculty of Science 
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and Technology, Universiti Kebangsaan Malaysia. The 
study animals were housed in cages and maintained on 
standard laboratory rat chow with water ad-libitum. All 
rats were acclimatised for two weeks before the initiation 
of the experimentation in order to adapt the rats with the 
environmental conditions. The experiments were performed 
after the approval of the protocol by Universiti Kebangsaan 
Malaysia Animal Ethics Committee (UKMAEC) and were 
carried out in accordance with the current guidelines 
for the care of laboratory animals (Approval No. FST/
SBB/2010/HALIMAH/24-AUGUST/322-SEPTEMBER-
2010-NOVEMBER-2011).
 INDUCTION OF DIABETES
Diabetes was induced in overnight-fasted rats (8 weeks 
old) (n = 30) each via a single intravenous injection of 
STZ (Calbiochem, La Jolla, USA) (45 mg/kg body weight; 
freshly dissolved in ice cold citrate buffer 0.1 M, pH4.5). 
Normal control animals (n = 6) received injection of 
sodium citrate buffer (pH4.5). 
 After one week, overnight-fasted rats (n = 30) with 
marked hyperglycemia (blood glucose level exceeding 
12.0 mmol/L) were selected and used for the study (Pandit 
et al. 2010).
EXPERIMENTAL PROTOCOL
The experimental design involved 36 rats which were 
divided into six groups (n = 6 per group).
 Animals in Group 1 were normal rats and served 
as the non-diabetic control group. Animals in Groups 
2 through 6 were STZ-induced diabetic rats. Group 2 
served as diabetic-untreated control. Animals in Group 
3 were administered orally with the reference drug, 
Glibenclamide (Sigma Chemical Co., St. Louis, USA) (5 
mg/kg b.w./day) which served as the diabetic positive 
control group. Rats in Groups 4, 5 and 6 were forced-
fed orally with G. procumbens fractions (hexane, ethyl 
acetate and n-butanol) respectively at 250 mg/kg b.w./day. 
Animals were given assigned treatments for two weeks 
(1 mL/rat). G. procumbens fractions and Glibenclamide 
were suspended in 0.2% carboxymethyl cellulose (CMC) 
prepared in distilled water prior to oral administration to 
experimental animals. Control Groups 1 and 2 were only 
administered the vehicle (0.2% CMC). 
 Fasting blood glucose levels were determined on 
day 0 (start of treatment) and day 14 (end of treatment). 
At the end of treatments (day 14), overnight-fasted rats 
were anesthetised and liver organs collected for analysis. 
The livers were removed immediately, frozen in liquid 
nitrogen and subsequently stored at -80°C. These frozen 
liver tissues were later used for glycogen content analysis 
and protein extraction for GSK3 western blot analysis.
DETERMINATION OF BLOOD GLUCOSE LEVELS
Blood samples were collected from the tail vein of 
overnight fasted rats on day 0 (start of treatment) and day 
14 (end of treatment) for determination of blood glucose 
levels using AccuCheck® Active Glucometer (Roche 
Diagnostics, Laval, Canada) 
DETERMINATION OF GLYCOGEN CONTENT
Liver glycogen content was determined according to 
the method described by (Ong & Khoo 2000). Weighed 
amounts of liver tissues were homogenised in 30% 
potassium hydroxide (KOH) and boiled at 100°C for 
30 min. Glycogen was precipitated with 95% ethanol, 
pelleted, washed and resolubilised in distilled water. 
Glycogen content was determined by a color reaction with 
anthrone reagent and measured spectrophotometrically at 
a wavelength of 590 nm.
WESTERN BLOTTING
Proteins from liver tissues were extracted using protein 
extraction buffer (Lipina et al. 2005) and the amount of 
protein measured using the Bradford Reagent following 
manufacturer instructions, with bovine serum albumin 
(BSA) as a standard. A total of 40 µg protein from 
each sample was separated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli 
1970), transferred onto polyvinylidene fluoride (PVDF) 
(Towbin et al. 1979) membranes and then blocked in 2.5% 
BSA in tris buffered saline-Tween 20 (TBST) (0.1% (w/v) 
Tween-20 in TBS). The membranes were then probed using 
a rabbit monoclonal antibody to rat GSK3β (Cell Signaling 
Technology, Inc., Danvers, USA) or rat monoclonal 
antibody to rat phospho-Ser GSK3β (Cell Signaling 
Technology, Inc., Danvers, USA) or mouse polyclonal 
anti-β-actin (Santa Cruz Biotechnology, Inc., Santa 
Cruz, USA). After incubation with secondary horseradish 
peroxidase-conjugated antibody, immunoreactive bands 
were developed using Enhanced Chemiluminescence (ECL) 
Plus western blotting detection system (Thermo Scientific, 
Rockford, USA). Band area intensity was quantified using 
a densitometer (Vilbert Lourmat 302, France).
STATISTICAL ANALYSIS
All data were expressed as mean ± Standard Error Mean 
(SEM). Statistical significance between groups were 
determined using one-way ANOVA and using Student’s 
t-test unpaired between two groups. p values < 0.05 were 
considered statistically significant.
RESULTS AND DISCUSSION
The present study was undertaken to re-evaluate the 
reported anti-diabetic activities of G. procumbens (Zhang 
& Tan 2000; Akowuah et al. 2001a,b; Rasadah et al. 
2002; Zurina et al. 2010) by using three different fractions 
prepared from the ethanolic extract of the plant (hexane, 
ethyl acetate and n-butanol fractions) in an experimentally-
induced animal diabetes model. Western analyses of 
liver samples from plant fraction-treated diabetic rats 
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were performed to determine whether GSK3 is involved 
in the anti-hypoglycemic effects of G. procumbens. In 
order to examine the potential of G. procumbens fractions 
in reducing blood glucose levels, a commercial anti-
diabetic drug, Glibenclamide was used as a positive 
control. Glibenclamide, an anti-diabetic drug in a class of 
medication known as sulfonylureas, is established to act 
by stimulating release of insulin from the pancreatic beta 
(β) cells (Luzi & Pozza 1997). 
 Out of a total of 44 experimental animals injected 
with a single intravenous injection of STZ (45 mg/kg 
body weight), diabetes was successfully induced in 31 
(70%) of the rats with blood glucose levels ranging from 
15.8 to 21.3 mmol/L (Table 1) i.e. exceeding the limit of 
12.0 mmol/L recognised as the accepted minimum blood 
glucose level for experimental hyperglycemia (Murphy & 
Anderson 1974). One of the major symptoms in diabetes 
is the impairment of glucose storage capacity attributed to 
the lack of activity of glycogen synthase, the rate-limiting 
enzyme in glycogenesis, in addition to defective glucose 
uptake activity of the cells (Cline et al. 2002). 
 In the present study, the impaired capacity of the 
liver to synthesise glycogen in diabetes is reflected by 
the reduced glycogen content in liver of diabetic rats 
(Figure 1). 
 Repeated oral administration of hexane, ethyl acetate 
and n-butanol fractions of G. procumbens into diabetic rats 
for 14 days caused significant (p < 0.05) reduction in blood 
glucose levels of 29.7%, 60.1% and 33.5%, respectively 
(Table 1). At the dose tested (250 mg/kg b.w/day), the ethyl 
acetate G. procumbens fraction exhibited glucose-reducing 
activity that is doubled the activities detected in the other 
TABLE 1.  Effects of G. procumbens leaf fractions on blood glucose 
levels in STZ-induced diabetic rats
Test model        Groups
Dose
(mg/kg)
Blood glucose levels (mmol/L)
 (Inhibition %) 
Day 0
(Start of treatment)
Day 14
(End of treatment)
Normal Control (Vehicle) - 5.4 ± 0.21 5.3 ± 0.25*
Diabetic Control (Vehicle) - 21.1 ± 1.01 27.7 ± 1.09
Glibenclamide 5 20.1 ± 1.33 7.7 ± 0.66 (61.7)*
Hexane fraction 250 19.5 ± 1.06 13.7 ± 0.80 (29.7)*
Ethyl acetate fraction 250 21.3 ± 1.62 8.5 ± 0.71 (60.1)*
n-butanol fraction 250 20.0 ± 1.13 13.8 ± 1.47 (33.5)*
Values are given as mean ± S.E.M. Diabetic controls were compared with normal controls and treated groups at the corresponding time. Values are statistically significant 
at *p < 0.05 vs diabetic control
FIGURE 1.  Effects of G. procumbens fractions on glycogen content of liver tissue in STZ-
induced diabetic rats Values are given as mean ± S.E.M. Diabetic controls were compared 
with normal controls and treated groups at the corresponding time-interval. Values are 
statistically significant at *p < 0.05 vs diabetic control
*
*
*
*
*
*
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two fractions; and was as pronounced as the activity 
observed with the standard oral hypoglycemic drug, 
Glibenclamide which reduced blood glucose by 61.7% 
(p < 0.0001). The differential blood glucose-reducing 
activities of the G. procumbens fractions examined in the 
present study may be accounted for by the differences in 
phytochemical constituents and composition among the 
three fractions. In the present investigation, phytochemical 
analysis of the plant fractions using HPLC revealed that 
the hexane and n-butanol fractions contain the flavonoid, 
kaempferol whilst the ethyl acetate fraction contained 
kaempferol-3, 7-di-O-β-D-glucoside. This latter compound 
has been shown to be responsible for anti-hyperglycemic 
activity in an ethanol extract of Gynura medica (Liu et al. 
2010).
 Oral administration of the fractions or Glibenclamide 
into diabetic rats also increased liver glycogen content 
significantly (p < 0.05) (Figure 1). The increase in liver 
glycogen level was higher in rats administered with hexane 
and n-butanol fractions of the plant compared with rats 
given the ethyl acetate fraction. Treatment with the ethyl 
acetate fraction however, increased hepatic glycogen 
content to a similar level as seen in Glibenclamide-treated 
rats. The results obtained with G. procumbens fractions as 
well as Glibenclamide indicated that the impaired glycogen 
storage of the diabetic state was partially corrected by the 
fractions of the reference drug. 
 Western analysis showed the presence of phosphorylated 
GSK3, pGSK3(Ser-9) in liver samples obtained from 
both groups of rats administered with plant fractions or 
Glibenclamide (Figure 2). Hepatic GSK3β in non-treated 
diabetic rats remained in the non-phosphorylated state. 
This kinase enzyme remains active in the diabetic state 
to phosphorylate glycogen synthase thus explaining the 
lowered levels of liver glycogen in the animals with diabetes 
as described earlier. 
 Despite the differences in chemical composition 
between the hexane, ethyl acetate and n-butanol plant 
fractions, there were no significant differences (p > 
0.05) between the hepatic pGSK3(Ser-9) levels in rats 
administered with these fractions as estimated from the 
immunoreactive band intensities (Figure 2). It was also 
interesting to note that the band intensity of the hepatic 
pGSK3 obtained from Glibenclamide-treated rats was 
similar to that in plant fractions-administered animals. 
 Since phosphorylation of Ser-9 in GSK3β leads to 
inhibition of the kinase enzyme activity (Yin et al. 2009), 
data obtained in the present study from western analysis 
using pGSK3β (Ser-9) antibody suggest that G. procumbens 
fractions or Glibenclamide inhibited GSK3β. How GSK3β is 
inactivated by G. procumbens was next addressed. 
 In insulin signaling, GSK3β activity is regulated by 
upstream components of the pathway including the level 
of insulin interacting at the receptor level. Work in our 
laboratory using crude ethanol G. procumbens extract 
showed that in extract-treated rats, the plasma insulin 
remained low as in non-treated diabetic control (Table 
2). It was unlikely that the action of G. procumbens 
involved stimulation of β cells of the pancreas. That G. 
procumbens action mimics insulin effects as previously 
suggested by Zurina et al. (2010) for the aqueous extract 
of G. procumbens thus was reiterated by the plasma insulin 
data (Table 2) obtained in the present study. Therefore, 
the GSK3β inhibition observed in liver of G. procumbens-
administered diabetic rats was not likely to be caused by 
potentiation of insulin production in the pancreas. The 
ethanol and methanol G. procumbens extracts exerted 
significant hypoglycemic effects (p < 0.05) in STZ-induced 
diabetic rats after administration of the extracts (Akowuah 
et al. 2001a,b; Zhang & Tan 2000). Contrary to the plasma 
insulin data obtained in the present study for the ethanol 
G. procumbens extract; and that obtained by Zurina et 
al. (2010) using an aqueous extract of the same plant, 
Rasadah et al. (2002) reported that the methanol extract 
of G. procumbens increased insulin secretion significantly 
(p < 0.05) in BRIN-BD11 cells. 
 A yeast-based GKS3 assay was further employed to test 
if the G. procumbens fraction-mediated phosphorylation of 
FIGURE 2.  GSK3β expression in liver of normal and STZ-induced diabetic rats. Liver protein extracts from glibenclamide-treated 
and G. procumbens fractions-treated animals or control animals were subjected to immunoblot analyses with the indicated 
antibodies. Lanes represent livers from 1: Normal control rats; 2: Diabetic control rats; 3: Glibenclamide (5 mg/kg)-treated diabetic 
rats; 4: G. procumbens hexane fraction (250 mg/kg)-treated diabetic rats; 5: G. procumbens ethyl acetate fraction (250 mg/kg)-
treated diabetic rats; and 6: G. procumbens butanol fraction (250 mg/kg)-treated diabetic rats
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GSK3β in diabetic rats was directly due to GSK3 inhibitory 
activities present in the plant fractions. All the three plant 
fractions tested showed no significant GSK3 inhibitory 
activities even at concentrations of up to 10 mg of the 
fractions tested (Table 3). Growth inhibition of the yeast 
transformant was not observed at 37ºC indicating these 
fractions was not targeting GSK3β. The hypoglycemic action 
of G. procumbens fractions could therefore be affecting 
component(s) upstream of the pathway that regulates GSK3 
activity. In this aspect, possible candidates as targets for 
anti-diabetic action in the insulin signaling pathway are 
PI3-kinase and PKB/Akt (Rayasam et al. 2009).
 In the insulin signaling pathway, Akt-mediated 
phosphorylation and inhibition of GSK3β in response to 
insulin resulted in the activation of glycogen synthase 
(Lizcano & Aleesi 2002).  The activation of glycogen 
synthase was then promoting glycogen synthesis, which 
constituted an important mechanism of glycemic control. 
In diabetes, GSK3β remains non-phosphorylated and 
activated resulting in lowered glycogen content in liver; 
this was due to the lack of stimulation of the insulin 
pathway. In the present study, the hexane, ethyl acetate 
and n-butanol fractions of G. procumbens were able to 
reduce blood glucose levels, partially restore hepatic 
glycogen-storage capacity and inhibit liver GSK3β in STZ-
induced diabetic rats. In addition to the blood glucose 
reducing activities, the plant fractions did not exhibit 
significant GSK3-inhibitory activity as assessed by an in 
vitro assay; and did not affect plasma insulin levels in the 
diabetic animals. 
CONCLUSION
A majority of the glucose-reducing agents available 
for the treatment of diabetes mellitus consists of agents 
which improve insulin production by β cells.  Here it 
was shown that G. procumbens was able to lower blood 
glucose without affecting plasma insulin levels. Therefore, 
it was likely that the hypoglycemic action of the fractions 
observed could be due to direct or indirect effects on the 
activities of one or more of the upstream components 
of the insulin biosignaling pathway. Thus, isolation and 
purification efforts towards identification of the active 
principle in the G. procumbens fractions responsible 
for these activities as well as determination of upstream 
kinases involved are pertinent.
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TABLE 3. No inhibitory activity of G. procumbens against GSK-3 using yeast based GSK-3 assay
Fraction
(Solvent)
Concentration
(mg/ml)
mg of sample
per disk
Inhibition zone (mm) Activity37°C 25°C
Hexane 125 (80 μL) 10 0 0 No activity
BuOH 125 (80 μL) 10 0 0 No activity
Ethyl acetate    125 (80 μL) 10 0 0 No activity
H7667 (Positive control) - 4   15 0 Positive
TABLE 2. Effect of G. procumbens crude ethanolic extract on plasma 
insulin in STZ-induced diabetic rats
Test model       Groups Dose (mg/kg) Plasma insulin (ng/ml)
        Day 42
(End of treatment)
Normal Control (Vehicle)        - 1.459 ± 0.113
Diabetic Control (Vehicle)        - 0.145 ± 0.0161**
Glibenclamide       5 0.189 ± 0.0076*
G. procumbens       50 0.144 ± 0.0252
G. procumbens       100 0.159 ± 0.0169
G. procumbens       150 0.156 ± 0.0158
Values are given as mean ± S.E.M. Diabetic controls were compared with normal controls and treated groups at the corresponding time-interval. Values 
are statistically significant at **p < 0.001 and *p < 0.05
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